Inventor · disambiguated record
Kyogo Itoh
Also filed as: ITOH KYOGO
27 granted patents·20 pending applications·71 citations·filing 1997–2017
95Inventor score
Top patents by PatentIndex Score
47 records- 0189US7718614B2Combination therapy of peptide vaccination and estramustine treatmentUNIV KURUME·Filed 2006·Granted May 18, 2010·7 cites·4 claims
- 0283US9102715B2CTL inducer compositionITOH KYOGO·Filed 2008·Granted Aug 11, 2015·6 cites·7 claims
- 0383US7655751B2Epidermal growth factor receptor-derived peptidesGREENPEPTIDE CO LTD·Filed 2005·Granted Feb 2, 2010·6 cites·2 claims
- 0476US7524930B2Tumor antigenGREENPEPTIDE CO LTD·Filed 2006·Granted Apr 28, 2009·1 cites·3 claims
- 0576US7432354B2Tumor antigenGREENPEPTIDE CO LTD·Filed 2006·Granted Oct 7, 2008·1 cites·3 claims
- 0676US7427660B2Tumor antigenGREENPEPTIDE CO LTD·Filed 2006·Granted Sep 23, 2008·1 cites·3 claims
- 0776US7408037B2Tumor antigenGREENPEPTIDE CO LTD·Filed 2006·Granted Aug 5, 2008·1 cites·3 claims
- 0870US7368107B2Tumor antigen peptides derived from cyclophilin BDAINIPPON SUMITOMO PHARMA CO·Filed 2005·Granted May 6, 2008·1 cites·4 claims
- 0970US7160545B2HLA-A24 binding peptides of enhancer of zeste homolog 2GREENPEPTIDE CO LTD·Filed 2005·Granted Jan 9, 2007·1 cites·1 claims
- 1066US7148326B2Tumor antigenGREENPEPTIDE CO LTD·Filed 2003·Granted Dec 12, 2006·1 cites·3 claims
- 1166US2010015169A1Tumor AntigensGREENPEPTIDE CO LTD·Filed 2009·Application pending·0 cites
- 1265US7968676B2Tumor antigen protein SART-3 and tumor antigen peptides thereofGREENPEPTIDE CO LTD·Filed 2009·Granted Jun 28, 2011·0 cites·6 claims
- 1363US7404270B2Tumor antigenGREENPEPTIDE CO LTD·Filed 2006·Granted Jul 29, 2008·0 cites·3 claims
- 1458US2005020817A1Tumor antigen proteins, genes therefor, and tumor antigen peptidesKYOGO ITOH·Filed 2004·Application pending·0 cites
- 1556US8563684B2Tumor antigen protein SART-3 and tumor antigen peptides thereofITOH KYOGO·Filed 2011·Granted Oct 22, 2013·0 cites·4 claims
- 1655US8097697B2Tumor antigen protein SART-3 and tumor antigen peptides thereofITOH KYOGO·Filed 2011·Granted Jan 17, 2012·0 cites·6 claims
- 1755US7541428B2Tumor antigen protein SART-3 and tumor antigen peptides thereofGREENPEPTIDE CO LTD·Filed 2004·Granted Jun 2, 2009·0 cites·7 claims
- 1855US7465452B2Tumor antigenGREENPEPTIDE CO LTD·Filed 2002·Granted Dec 16, 2008·0 cites·3 claims
- 1955US2004141992A1DesensitizersFiled 2004·Application pending·0 cites
- 2055US2008031888A1Tumor antigensITOH KYOGO·Filed 2007·Application pending·0 cites
- 2154US9642900B2CTL inducer compositionGREENPEPTIDE CO LTD·Filed 2015·Granted May 9, 2017·0 cites·10 claims
- 2254US2017354726A1Cancer peptide vaccineGREENPEPTIDE CO LTD·Filed 2017·Application pending·0 cites
- 2353US6555652B1Tumor antigen peptide derivativesKYOGO ITOH·Filed 1998·Granted Apr 29, 2003·18 cites·7 claims
- 2452US8030443B2Squamous cell carcinoma antigen-derived peptide binding to HLA-A24 moleculeUNIV KURUME·Filed 2006·Granted Oct 4, 2011·0 cites·2 claims
- 2552US2017202913A1Ctl inducer compositionGREENPEPTIDE CO LTD·Filed 2017·Application pending·0 cites
- 2651US6664232B1HLA-A2 restraint tumor antigen peptide originating in SART-1KYOGO ITOH·Filed 1999·Granted Dec 16, 2003·10 cites·7 claims
- 2751US2013164314A1Cancer peptide vaccineITOH KYOGO·Filed 2011·Application pending·0 cites
- 2850US2005130899A1Tumor antigensFiled 2002·Application pending·0 cites
- 2949US7968098B2HLA-A24-binding KIF-derived peptideUNIV KURUME·Filed 2007·Granted Jun 28, 2011·0 cites·8 claims
- 3047US2015216958A1Cancer peptide vaccineGREENPEPTIDE CO LTD·Filed 2015·Application pending·0 cites
- 3145US2008254445A1Prognosis in Cancer Patients Vaccinated with a Cancer Antigen Peptide-Associated AgentITOH KYOGO·Filed 2003·Application pending·0 cites
- 3243US7071294B1Tumor antigen protein art-1 and tumor antigen peptide thereofGREENPEPTIDE CO LTD·Filed 1999·Granted Jul 4, 2006·4 cites·10 claims
- 3343US2010184699A1Peptide Derived From Prostate-Related Protein As Cancer Vaccine Candidate For Prostate Cancer Patient Who Is Positive For Hla-A3 Super-Type Allele MoleculeITOH KYOGO·Filed 2006·Application pending·0 cites
- 3443US2005042624A1Tumor antigenKYOGO ITOH·Filed 2003·Application pending·0 cites
- 3542US2006035291A1Method of detecting cellular immunity and application thereof to drugsITOH KYOGO·Filed 2002·Application pending·0 cites
- 3641US2008063643A1Peptide Derived From Hepatitis C VirusGREENPEPTIDE CO LTD·Filed 2004·Application pending·0 cites
- 3741US2008286313A1Peptide Vaccines for the Treatment of CancersITOH KYOGO·Filed 2005·Application pending·0 cites
- 3840US6248533B1Gene diagnosis of diseases wherein TNF-α promotors participateSHIONOGI & CO·Filed 1999·Granted Jun 19, 2001·6 cites·4 claims
- 3940US2005019341A1Tumor antigenFiled 2002·Application pending·0 cites
- 4039US2008014186A1Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related ProteinGREENPEPTIDE CO LTD·Filed 2005·Application pending·0 cites
- 4139US2010292138A1Peptide Derived from Hepatitis C VirusGREENPEPTIDE CO LTD·Filed 2007·Application pending·0 cites
- 4238US2013157893A1Method for predicting therapeutic effect of immunotherapy on cancer patient, and gene set and kit to be used in the methodITOH KYOGO·Filed 2011·Application pending·0 cites
- 4337US7041297B1Tumor antigen peptides originating in cyclophilin BKYOGO ITOH·Filed 1999·Granted May 9, 2006·3 cites·3 claims
- 4436US2013023432A1Method for predicting therapeutic effect of immunotherapy on cancer patient and/or prognosis after immunotherapy, and gene set and kit to be used therinUNIV KURUME·Filed 2010·Application pending·0 cites
- 4535US6815531B1Tumor antigen proteins, genes thereof, and tumor antigen peptidesITOH KYOGO·Filed 1997·Granted Nov 9, 2004·4 cites·4 claims
- 4627US6838445B1Tumor antigen peptide originating in SART-1KYOGO ITOH·Filed 1999·Granted Jan 4, 2005·0 cites·6 claims
- 4727US6528635B1Tumor antigen protein, gene thereof, and utilization thereofITOH KYOGO·Filed 1998·Granted Mar 4, 2003·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Kyogo Itoh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →